Cardura: Effective Blood Pressure and BPH Symptom Control
| Product dosage: 1mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 120 | $0.33 | $40.16 (0%) | 🛒 Add to cart |
| 180 | $0.31 | $60.24 $56.23 (7%) | 🛒 Add to cart |
| 270 | $0.29 | $90.36 $78.32 (13%) | 🛒 Add to cart |
| 360 | $0.26
Best per pill | $120.49 $94.38 (22%) | 🛒 Add to cart |
| Product dosage: 2mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.87 | $52.21 (0%) | 🛒 Add to cart |
| 90 | $0.79 | $78.32 $71.29 (9%) | 🛒 Add to cart |
| 120 | $0.76 | $104.42 $91.37 (12%) | 🛒 Add to cart |
| 180 | $0.73 | $156.63 $130.53 (17%) | 🛒 Add to cart |
| 270 | $0.70 | $234.95 $189.76 (19%) | 🛒 Add to cart |
| 360 | $0.67
Best per pill | $313.26 $241.97 (23%) | 🛒 Add to cart |
Cardura (doxazosin mesylate) is an alpha-1 adrenergic blocker medication prescribed for the management of hypertension (high blood pressure) and the treatment of symptomatic benign prostatic hyperplasia (BPH). It functions by relaxing blood vessels and smooth muscle in the prostate and bladder neck, facilitating easier blood flow and improved urinary function. This dual-action mechanism makes it a versatile option in a clinician’s therapeutic arsenal for addressing two prevalent conditions, often with a single agent.
Features
- Active pharmaceutical ingredient: Doxazosin mesylate.
- Available in scored tablet formulations for ease of dose titration (1 mg, 2 mg, 4 mg, 8 mg).
- Selective antagonist of postsynaptic alpha-1 adrenergic receptors.
- Administered via oral route, typically once daily.
- Manufactured under stringent quality control standards to ensure potency and purity.
Benefits
- Effectively lowers both systolic and diastolic blood pressure, reducing the long-term risk of cardiovascular events, stroke, and kidney damage.
- Provides rapid relief from obstructive and irritative symptoms of BPH, such as weak stream, hesitancy, and nocturia, improving quality of life.
- Offers a favorable hemodynamic profile, making it a suitable option for patients with concomitant hypertension and BPH.
- The once-daily dosing regimen promotes excellent patient adherence and convenience.
- Can be used as monotherapy or in combination with other antihypertensive agents (e.g., diuretics, beta-blockers, ACE inhibitors) for additive blood pressure control.
Common use
Cardura is primarily indicated for two conditions. First, for the management of hypertension, either as monotherapy or in combination with other antihypertensive drugs. It is effective in a wide range of patient demographics. Second, for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH). It is used to relieve urinary obstruction and associated symptoms, improving urinary flow and reducing bladder outlet obstruction. It is not intended for use as an intervention for prostate cancer.
Dosage and direction
Dosage must be individualized based on the patient’s therapeutic response and tolerability. For both hypertension and BPH, treatment must be initiated with a 1 mg dose taken once daily to minimize the potential for exaggerated hypotensive response. The dosage may then be titrated upward, typically at 1-2 week intervals, depending on the patient’s blood pressure response or BPH symptom relief. The usual recommended therapeutic dosage range is 2-8 mg once daily. The maximum recommended daily dose for hypertension is 16 mg, though most patients respond to 8 mg or less. For BPH, the recommended dosage range is 1-8 mg once daily, with 4 mg and 8 mg doses demonstrating the greatest efficacy in clinical studies. Tablets should be swallowed whole, with or without food, and preferably at the same time each day. The 2 mg, 4 mg, and 8 mg tablets are scored and can be divided for ease of dose titration.
Precautions
Patients beginning treatment with Cardura are susceptible to a marked hypotension, occasionally manifesting as syncope (fainting), with sudden loss of consciousness. This effect is most common within the first few hours of the initial dose or during subsequent dosage increases. It is associated with dizziness, lightheadedness, and palpitations. Patients should be advised to avoid situations where injury could result should syncope occur during this period. Caution is advised when driving or operating machinery. Intraoperative Floppy Iris Syndrome (IFIS) has been observed during cataract surgery in patients on or previously treated with alpha-1 blockers like doxazosin. This may complicate the surgical procedure. Ophthalmologists should be informed of a patient’s use of this medication prior to any eye surgery. As with any antihypertensive, use with caution in patients with severe hepatic impairment.
Contraindications
Cardura is contraindicated in patients with a known hypersensitivity to doxazosin, other quinazolines (e.g., prazosin, terazosin), or any component of the formulation. Its use is also contraindicated in patients with a history of orthostatic hypotension or priapism, a painful and prolonged erection unrelated to sexual activity, which has been associated with alpha-1 blocker use.
Possible side effect
Like all medications, Cardura can cause side effects, although not everybody gets them. Common side effects include: dizziness, somnolence (sleepiness), fatigue, asthenia (weakness), postural dizziness, and edema (swelling). Syncope (fainting) is a less common but serious side effect, particularly at therapy initiation. Other reported adverse reactions include headache, nausea, rhinitis (nasal congestion), and hypotension. Priapism, though rare, is a urological emergency requiring immediate medical intervention to prevent permanent tissue damage. Patients should be instructed to report any erection lasting more than 4 hours.
Drug interaction
Concomitant use of Cardura with other antihypertensive agents or phosphodiesterase-5 (PDE-5) inhibitors (e.g., sildenafil, tadalafil, vardenafil) used for erectile dysfunction or pulmonary hypertension may potentiate the blood pressure-lowering effects and increase the risk of hypotension, including orthostatic hypotension and syncope. Caution is warranted with such combinations. Doxazosin is primarily metabolized by the liver via CYP3A4; therefore, potent inhibitors of this enzyme (e.g., ketoconazole, itraconazole, ritonavir) may increase doxazosin plasma concentrations and its effects. Inducers of CYP3A4 (e.g., rifampin) may decrease its plasma concentration.
Missed dose
If a dose is missed, it should be taken as soon as remembered on the same day. If it is not remembered until the next day, the patient should skip the missed dose and resume the usual dosing schedule. The dose should not be doubled to make up for a forgotten tablet.
Overdose
In the event of an overdose, the primary expected manifestation is exaggerated hypotension, sometimes accompanied by shock. Supportive care is the mainstay of treatment. This includes placing the patient in a supine position, elevating the legs, and actively managing circulatory support with intravenous fluids and vasopressors if necessary. Gastric lavage or induced emesis may be considered if ingestion was recent. As doxazosin is highly protein-bound, dialysis is not likely to be of benefit.
Storage
Store Cardura tablets at room temperature, between 20°C to 25°C (68°F to 77°F), in a tightly closed container. Protect from light and moisture. Keep all medications out of the reach of children and pets. Do not use after the expiration date printed on the packaging.
Disclaimer
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any new treatment. Never disregard professional medical advice or delay in seeking it because of something you have read here.
Reviews
“After starting my father on Cardura 4 mg for his BPH, his nightly trips to the bathroom reduced from 4-5 to just 1. The improvement in his sleep and overall daytime energy has been remarkable. Titration was key; we started at 1 mg to avoid dizziness.” – Dr. Evan R., Urologist
“As a cardiologist, I find Cardura to be a valuable tool, especially in male patients with concomitant hypertension and BPH. It effectively manages both conditions with a single agent, simplifying the regimen and improving adherence. The first-dose effect is a critical consideration we always discuss with patients.” – Dr. Sarah L., Cardiologist
“Initial dizziness was a challenge, but my doctor started me on the lowest dose and it subsided within a week. My blood pressure is now consistently in the normal range, and I haven’t experienced any other side effects. The convenience of one pill a day is a major plus.” – Mark T., Patient